HAYWARD, CA – Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces that the US Patent and Trademark Office has issued US Patent No. 9,138,205 for a Sample Recovery and Collection Device.
The issuance of this patent is a first step towards our vision of providing efficient and simple to use biosample collection technologies. The recognition of our sample collection technology by leading researchers affirms that we are on the right track for fulfilling the mission our company has been founded upon, which is improving human and animal health assessment and research by enabling efficient, cost effective collection, preservation and transportation of biological samples,” said Dr. Bassam El-Fahmawi, President and CTO of Mawi DNA Technologies.
The patent covers the elements used in Mawi’s iSWAB technology , an integrated system that combines a unique biosample collection and concentration device with a variety of proprietary buffer formulations that enable room temperature stabilization of DNA, RNA, proteins, and oral samples for drug screening. Mawi DNA Technologies’ product development pipeline includes iSWAB-Blood designed to overcome current challenges in Dry Blood Spot collection, as well as a potentially disruptive new formula for stabilizing live, intact cells at ambient conditions for extended time periods.
About Mawi DNA Technologies:
Mawi DNA Technologies was founded in 2013 and has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. The company’s flagship product iSWAB-DNA has gained significant market traction due to its ability to be utilized for animals and all human population segments from infants to elderly, robust DNA yield, and low bacterial DNA content. Mawi DNA Technologies has established relationships with well known children’s hospitals for neonatal screening, and has set up an extensive network of international distributors to market and sell iSWAB products globally. For more information, please visit our website at https://www.mawidna.com
Alternative To Blood Samples Exome Sequencing Screening...
In a study published by the NPJ Genomic Medicine, Three young children presented with a neurodevelopmental disorder were studied to identify if there were pathogenic variants found in their ATG4D bi-...
READ MOREHigh-Efficiency Collection and Release Of Oral DNA Samples...
"The full release capacity functionality allows for adequate sample capture needed for DNA sample collection and processing." Mawi DNA Technologies, a medical device company fo...
READ MOREMeet The Mawi DNA Team We’ll be exhibiting at Booth…...
JOIN US AT ASHG | Nov 1-5, 2023 | Walter E. Washington Convention Center| Washington, D.C Mawi DNA Technologies improves the biological sample collection process with innovative technologies. Our ...
READ MORE
